マサチューセッツ州における脳腫瘍の臨床試験
マサチューセッツ州内の拠点で、脳腫瘍に関する29件の研究が参加者を募集しています。
マサチューセッツ州内の都市
公式研究テキスト（英語）
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
- Dana Farber Cancer Institute, Boston
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07326566Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Tufts Medical Center, Boston
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/24更新 · NCT06047379Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Dana-Farber Cancer Institute, Boston
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT05786924A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Local Institution - 0124, Boston
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07492680A Phase 1/1b Study of IAM1363 in HER2 Cancers
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06253871Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
被験者募集中
18歳以上 · 全性別 · 2026/09/09更新 · NCT04033497Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/09更新 · NCT04899908Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- Dana-Farber Cancer Institute, Boston
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/09更新 · NCT05386108Targeted Pediatric High-Grade Glioma Therapy
- Dana-Farber Cancer Institute, Boston
被験者募集中観察研究
12 Months – 39 Years · 全性別 · 2026/09/08更新 · NCT05839379A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
- Massachusetts General Hospital, Boston
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/08更新 · NCT07428616Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction
- Brigham and Women's Hospital / Dana-Farber Cancer Institute, Boston
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/08更新 · NCT07132190Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases
- Brigham and Women's Hospital, Boston
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/08更新 · NCT07130786B7-H3.CD28Z.CART in CNS Neoplasms
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
被験者募集中第1相
2歳〜21歳 · 全性別 · 2026/09/03更新 · NCT07390539Study of Olutasidenib and Temozolomide in HGG
- Susan Chi, Boston
被験者募集中第2相
12歳〜39歳 · 全性別 · 2026/09/01更新 · NCT06161974Local Control, Quality of Life and Toxicities in Adults With Benign or Indolent Brain Tumors Undergoing Proton Radiation Therapy
- Massachusetts General Hospital, Boston
被験者募集中
18歳以上 · 全性別 · 2026/08/24更新 · NCT03286335Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- Beth Israel Deaconess Medical Center, Boston
- Beth Israel Deaconess Medical Center, Boston
被験者募集中観察研究
全年齢 · 全性別 · 2026/07/22更新 · NCT04427384Palbociclib and Pembrolizumab In Central Nervous System Metastases
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/21更新 · NCT02896335Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
- Tufts Medical Center, Boston
被験者募集中第3相
18歳以上 · 全性別 · 2026/06/09更新 · NCT03550391Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Dana-Farber Cancer Institute, Boston
被験者募集中第2相
12 Months – 39 Years · 全性別 · 2026/05/29更新 · NCT05843253NTS-WBRT in Brain Metastases
- Massachusetts General Hospital Cancer Center, Boston
被験者募集中第2相
18歳以上 · 全性別 · 2026/04/16更新 · NCT05013892Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Dana Farber Cancer Institute, Boston
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/13更新 · NCT06810544NeuroPathways Intervention for Brain Tumor Patients
- Massachusetts General Hospital Cancer Center, Boston
被験者募集中
18歳以上 · 全性別 · 2025/12/17更新 · NCT05976490Stereotactic Magnetic Resonance Guided Radiation Therapy
- Brigham & Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
被験者募集中
18歳以上 · 全性別 · 2025/11/13更新 · NCT04115254S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- Lahey Hospital and Medical Center, Burlington
- Winchester Hospital, Winchester
被験者募集中第3相
18歳以上 · 全性別 · 2025/10/08更新 · NCT03418961A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
- Massachusetts General Hospital Cancer Center, Boston
被験者募集中早期第1相
18歳以上 · 全性別 · 2025/09/11更新 · NCT06552260A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
- Beth Israel Deaconess Medical Center, Boston
被験者募集中第1/2相
18歳〜89歳 · 全性別 · 2025/08/19更新 · NCT06907043ASCENT Intervention for Brain Tumor Patients
- Massachusetts General Hospital Cancer Center, Boston
被験者募集中
18歳以上 · 全性別 · 2025/07/14更新 · NCT06099743The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
- Massachusetts General Hospital, Boston
被験者募集中観察研究
90歳以下 · 全性別 · 2024/02/22更新 · NCT06273176The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
- Massachusetts General Hospital, Boston
被験者募集中観察研究
18歳〜90歳 · 全性別 · 2024/02/22更新 · NCT06118723ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。